ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science Read More »
ProSciento Closes Growth Financing from 1315 Capital Read More »
View Recent Webinar
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study. Read More »
Poster Presentations: American Diabetes Association 81st Scientific Sessions 2021 Read More »
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Read More »
